Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

396 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab for refractory focal segmental glomerulosclerosis.
Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K. Nakayama M, et al. Among authors: sako m. Pediatr Nephrol. 2008 Mar;23(3):481-5. doi: 10.1007/s00467-007-0640-x. Epub 2007 Nov 1. Pediatr Nephrol. 2008. PMID: 17973121
[Guidelines for the treatment of childhood IgA nephropathy].
Yoshikawa N, Igarashi T, Ishikura K, Kaku Y, Nakazato H, Kamei K, Kawamura T, Nakamura H, Yamamoto Y, Nakanishi K, Sako M. Yoshikawa N, et al. Among authors: sako m. Nihon Jinzo Gakkai Shi. 2008;50(1):31-41. Nihon Jinzo Gakkai Shi. 2008. PMID: 18318242 Japanese. No abstract available.
Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study.
Nakanishi K, Iijima K, Ishikura K, Hataya H, Awazu M, Sako M, Honda M, Yoshikawa N; Japanese Pediatric IgA Nephropathy Treatment Study Group. Nakanishi K, et al. Among authors: sako m. Pediatr Nephrol. 2009 Apr;24(4):845-9. doi: 10.1007/s00467-008-1006-8. Epub 2008 Sep 30. Pediatr Nephrol. 2009. PMID: 18825420 Clinical Trial.
Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N; Japanese Pediatric IgA Nephropathy Treatment Study Group. Kamei K, et al. Among authors: sako m. Clin J Am Soc Nephrol. 2011 Jun;6(6):1301-7. doi: 10.2215/CJN.08630910. Epub 2011 Apr 14. Clin J Am Soc Nephrol. 2011. PMID: 21493743 Free PMC article. Clinical Trial.
Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.
Iijima K, Sako M, Oba MS, Ito S, Hataya H, Tanaka R, Ohwada Y, Kamei K, Ishikura K, Yata N, Nozu K, Honda M, Nakamura H, Nagata M, Ohashi Y, Nakanishi K, Yoshikawa N; Japanese Study Group of Kidney Disease in Children. Iijima K, et al. Among authors: sako m. Clin J Am Soc Nephrol. 2014 Feb;9(2):271-8. doi: 10.2215/CJN.13071212. Epub 2013 Nov 21. Clin J Am Soc Nephrol. 2014. PMID: 24262503 Free PMC article. Clinical Trial.
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y; Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Iijima K, et al. Among authors: sako m. Lancet. 2014 Oct 4;384(9950):1273-81. doi: 10.1016/S0140-6736(14)60541-9. Epub 2014 Jun 22. Lancet. 2014. PMID: 24965823 Clinical Trial.
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment.
Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K; Japanese Study Group of Kidney Disease in Children. Yoshikawa N, et al. Among authors: sako m. Kidney Int. 2015 Jan;87(1):225-32. doi: 10.1038/ki.2014.260. Epub 2014 Jul 23. Kidney Int. 2015. PMID: 25054775 Free PMC article. Clinical Trial.
396 results